NEW YORK, Dec. 13, 2017 /PRNewswire/ -- New Jersey has convened its second trial of a transvaginal mesh lawsuit involving devices manufactured by Ethicon, Inc.
According to court documents pending in Bergen County Superior Court, the case was filed on behalf of a New Jersey woman who allegedly suffered painful complications following implantation of Ethicon's Prolift and TVT-Obturator devices to treat stress urinary incontinence. In opening arguments on November 27th, the Plaintiff's attorney asserted that Ethicon was aware that the polypropylene used in its pelvic mesh implants could potentially harm vaginal tissue, but failed to provide adequate warnings to patients and doctors. (Case No. L-13686-14)
"Our Firm is representing numerous women who have filed similar transvaginal mesh lawsuits against Ethicon. We are closely monitoring developments in this bellwether trial, as its outcome could provide clues to jury verdicts in similar cases involving Ethicon pelvic mesh products," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to investigate legal claims on behalf of women who suffered debilitating transvaginal mesh complications, allegedly due to products marketed by Ethicon and other medical device manufacturers.
Transvaginal Mesh Litigation
At least 9,000 transvaginal mesh lawsuits have been filed against Ethicon in the multicounty litigation now underway in New Jersey Superior Court. The current case is the first to go to trial since February 2013, when an Atlantic County Superior Court jury awarded $3.35 million in compensatory damages and $7.6 million in punitive damages to a woman who suffered serious complications following implantation of another Ethicon mesh device to treat pelvic organ prolapse. (In re Pelvic Mesh/Gynecare Litigation, No. 6341-10)
More than 50,000 similar transvaginal mesh lawsuits have been filed against Ethicon and its parent company, Johnson & Johnson, in courts around the country. Thousands of additional claims have been filed against American Medical Systems, Boston Scientific Corp., C.R. Bard, Inc. and other device manufacturers. Of 31 cases that have gone to trial, 22 have concluded with verdicts for the plaintiffs and damage awards in excess of $1 million.
While Ethicon and other manufacturers have settled large groups of cases, thousands of pelvic mesh lawsuits remain to be litigated.
Women who suffered serious complications allegedly associated with transvaginal mesh may be entitled to compensation for medical bills, lost wages, pain and suffering and more. To learn more, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no-obligation review of your potential claim.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs' firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2017 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
View original content with multimedia:http://www.prnewswire.com/news-releases/ethicon-transvaginal-mesh-lawsuit-goes-to-trial-in-new-jersey-bernstein-liebhard-llp-reports-300570834.html
SOURCE Bernstein Liebhard LLP